mRNA-Based Therapeutics Summit Leaderboard

More
- Sunday, March 30, 2025
- About
- Advertise
- Subscribe
- Contact

More

Home
Interviews
Exclusive Interview – Neuropathic Pain Therapeutics Digital Summit

Exclusive Interview – Neuropathic Pain Therapeutics Digital Summit

On Jun 10, 2021

Share

You might also like

Press Releases

The Tumour Models Summit Hits Sweden!

Press Releases

5th Genome Editing Therapeutics Summit is only 3 weeks away!

Press Releases

Celebrating More than a Decade of Excellence at the World ADC Awards – Winners…

Press Releases

Final Week to Save $350: Accelerate Your Gene Editing Program

Press Releases

An Interview with Jeffrey Cehelsky, Intellia Therapeutics

Press Releases

Hottest Gene Editing Events Causing Waves in 2024

Press Releases

A Timeline of Gene Editing Landmarks

Press Releases

Shaping the Future of Therapeutic Gene Editing

Press Releases

Join the Gene Editing Revolution This December

Press Releases

Cell Therapy Analytical and Quality Control Experts to Gather in Boston this December…

Prev Next

About Us

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts

Ionis Expands Partnership with Sobi for Olezarsen Commercialization Outside the U.S.
Soleno Therapeutics Wins FDA Approval for VYKAT XR to Treat Hyperphagia in Prader-Willi Syndrome
Merck’s Subcutaneous Pembrolizumab Shows Noninferior Pharmacokinetics to IV KEYTRUDA
European Commission Approves Merck’s CAPVAXIVE for Pneumococcal Disease in Adults
Character Biosciences Raises $93M Series B for Eye Disease Precision Medicine

Industry Reports

AbbVie Completes Acquisition of ImmunoGen

Sanofi to acquire Inhibrx, Inc., adding potential…

Esperion and Daiichi Sankyo Europe Announce $125 Million…

Avistone Biotechnology Announces Closing of Series B…

Apollo Therapeutics Closes $226.5 Million Series C…

Press Releases

The Tumour Models Summit Hits Sweden!

5th Genome Editing Therapeutics Summit is only 3 weeks…

Celebrating More than a Decade of Excellence at the World…

Final Week to Save $350: Accelerate Your Gene Editing…

An Interview with Jeffrey Cehelsky, Intellia Therapeutics

About
Advertise
Subscribe
Contact

Pharma Journalist is a product of

Sign in

Home
News
Drug Research
Clinical Trials
Manufacturing
Information Technology
Packaging & Labeling
Diseases
Resources
Events
Press Releases

About
Advertise
Subscribe
Contact

Welcome, Login to your account.

Forget password? Remember me

Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok Learn More